ImmunityBio
IBRX
IBRX
63 hedge funds and large institutions have $56.1M invested in ImmunityBio in 2017 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 23 increasing their positions, 14 reducing their positions, and 7 closing their positions.
Holders
63
Holders Change
+6
Holders Change %
+10.53%
% of All Funds
1.43%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
13
Increased
23
Reduced
14
Closed
7
Calls
$4K
Puts
$80K
Net Calls
-$76K
Net Calls Change
-$336K
Top Buyers
Top Sellers
1 |
WCM
1
Wildcat Capital Management
New York
|
$3.63M |
2 |
![]()
2
Fidelity Investments
Boston,
Massachusetts
|
$5.7M |
3 |
3
Invesco
Atlanta,
Georgia
|
$46K |
4 |
4
BlackRock
New York
|
$12.2M |
5 |
5
SG Americas Securities
New York
|
$0 |